Dr. Alejandro A Porrata Nieva, M.D. Pain Medicine - Interventional Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 29 Calle Washington, Ste. 303, San Juan, PR 00907 Phone: 787-721-2250 |
Dr. Dorian M Lopez-bracetty, MD Pain Medicine - Interventional Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 311 Ave Domenech, San Juan, PR 00918 Phone: 787-758-2525 Fax: 787-848-0318 |
Dr. Francisco Jose Irizarry Rivera, MD Pain Medicine - Pain Medicine Medicare: Medicare Enrolled Practice Location: 1395 Calle San Rafael, San Juan, PR 00909 Phone: 787-766-7070 |
News Archive
Scientists at Cold Spring Harbor Laboratory (CSHL) and the University of Southern California (USC) have uncovered intriguing new evidence helping to explain one of the ways in which a stem cell's fate can be determined.
Experts are warning that the long-term safety of screening embryos for genetic diseases is going unchecked.
These proteins are required for melanocyte stem cell self-maintenance and, as such, correct pigmentation throughout the mice's life span. Without these two proteins, the mice's fur turns white. Their research is published in the review 'Cell Report' and paves the way for serious possibilities in terms of stopping the formation of melanomas, tumours that originate from melanocyte cells.
Gene therapy for spinal muscular atrophy might have a high up-front price tag. But by screening and treating infants early, the therapy can save both lives and money in the long term.
Asuragen, Inc. announced today that it has entered into an exclusive agreement with Novartis to develop worldwide Armored RNA Quant BCR-ABL1 RNA International Scale Calibrators and laboratory software reporting tools, intended to aid laboratories with standardization of BCR-ABL1 RT-qPCR testing to the International Scale. As part of this agreement, Asuragen will develop and, if successful, distribute the ARQ BCR-ABL1 IS RNA Calibrators and software reporting tools to laboratories globally directly or through its distributors.
› Verified 4 days ago